Medartis Holding AG (SWX:MED)

Medartis Holding AG Statistics

Total Valuation

SWX:MED has a market cap or net worth of CHF 1.08 billion. The enterprise value is 1.08 billion.

Market Cap	1.08B
Enterprise Value	1.08B

Important Dates

The next estimated earnings date is Tuesday, March 17, 2026.

Earnings Date	Mar 17, 2026
Ex-Dividend Date	n/a

Share Statistics

SWX:MED has 12.42 million shares outstanding. The number of shares has decreased by -0.16% in one year.

Current Share Class	12.42M
Shares Outstanding	12.42M
Shares Change (YoY)	-0.16%
Shares Change (QoQ)	+9.93%
Owned by Insiders (%)	50.99%
Owned by Institutions (%)	6.85%
Float	3.03M

Valuation Ratios

PE Ratio	n/a
Forward PE	84.70
PS Ratio	4.57
PB Ratio	4.14
P/TBV Ratio	5.30
P/FCF Ratio	46.29
P/OCF Ratio	34.45
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 26.56, with an EV/FCF ratio of 46.43.

EV / Earnings	-2,225.40
EV / Sales	4.59
EV / EBITDA	26.56
EV / EBIT	56.24
EV / FCF	46.43

Financial Position

The company has a current ratio of 5.31, with a Debt / Equity ratio of 0.47.

Current Ratio	5.31
Quick Ratio	3.51
Debt / Equity	0.47
Debt / EBITDA	3.10
Debt / FCF	5.31
Interest Coverage	2.33

Financial Efficiency

Return on equity (ROE) is -0.14% and return on invested capital (ROIC) is 2.95%.

Return on Equity (ROE)	-0.14%
Return on Assets (ROA)	2.47%
Return on Invested Capital (ROIC)	2.95%
Return on Capital Employed (ROCE)	4.42%
Revenue Per Employee	204,097
Profits Per Employee	-421
Employee Count	949
Asset Turnover	0.51
Inventory Turnover	0.60

Taxes

In the past 12 months, SWX:MED has paid 245,000 in taxes.

Income Tax	245,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +48.12% in the last 52 weeks. The beta is 1.07, so SWX:MED's price volatility has been similar to the market average.

Beta (5Y)	1.07
52-Week Price Change	+48.12%
50-Day Moving Average	86.29
200-Day Moving Average	75.19
Relative Strength Index (RSI)	44.31
Average Volume (20 Days)	9,353

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, SWX:MED had revenue of CHF 236.34 million and -487,000 in losses. Loss per share was -0.05.

Revenue	236.34M
Gross Profit	186.96M
Operating Income	18.40M
Pretax Income	-140,000
Net Income	-487,000
EBITDA	33.34M
EBIT	18.40M
Loss Per Share	-0.05

Balance Sheet

The company has 120.51 million in cash and 123.88 million in debt, giving a net cash position of -3.37 million or -0.27 per share.

Cash & Cash Equivalents	120.51M
Total Debt	123.88M
Net Cash	-3.37M
Net Cash Per Share	-0.27
Equity (Book Value)	261.21M
Book Value Per Share	21.03
Working Capital	214.88M

Cash Flow

In the last 12 months, operating cash flow was 31.36 million and capital expenditures -8.02 million, giving a free cash flow of 23.34 million.

Operating Cash Flow	31.36M
Capital Expenditures	-8.02M
Free Cash Flow	23.34M
FCF Per Share	1.88

Margins

Gross margin is 79.11%, with operating and profit margins of 7.78% and -0.21%.

Gross Margin	79.11%
Operating Margin	7.78%
Pretax Margin	-0.06%
Profit Margin	-0.21%
EBITDA Margin	14.11%
EBIT Margin	7.78%
FCF Margin	9.88%

Dividends & Yields

SWX:MED does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	0.16%
Shareholder Yield	n/a
Earnings Yield	-0.05%
FCF Yield	2.16%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

SWX:MED has an Altman Z-Score of 3.69 and a Piotroski F-Score of 4.

Altman Z-Score	3.69
Piotroski F-Score	4